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Antimicrobial and cytotoxic 
activity of green synthesis silver 
nanoparticles targeting skin 
and soft tissue infectious agents
Javier Mussin1*, Viviana Robles‑Botero2, Rocío Casañas‑Pimentel2, Florencia Rojas1, 
Letizia Angiolella3, Eduardo San Martín‑Martínez4 & Gustavo Giusiano1
Combining traditional medicine with nanotechnology therefore opens the door to innovative 
strategies for treating skin and soft tissue infections (SSTIs) and also contributes to the fight against 
the rise of antimicrobial resistance. Acanthospermum australe (Loefl.) Kuntze is a medicinal plant 
used by indigenous peoples in northeastern Argentina to treat SSTIs. Spherical and stable silver 
nanoparticles (AgNPs) of 14 ± 2 nm were synthesized from the aqueous extract of A. australe and silver 
nitrate. The antimicrobial activity against main species causing SSTIs and cytotoxicity on peripheral 
blood mononuclear cells of AgNP solution and its synthesis components were evaluated. Compared to 
its synthesis components, AgNP solution showed greater antimicrobial activity and lower cytotoxicity. 
The antimicrobial activity of AgNPs was due to the silver and not to the metabolites of the aqueous 
extract present on the surface of the nanoparticles. The plant extract played an important role in the 
formation of stable AgNPs and acted as a modulator of cytotoxic and immune responses.
The skin is the largest organ of the human body and forms an integral part of the immune system, serving as the 
first line of defense against microbial infections. Skin and soft tissue infections (SSTIs) are a common reason for 
consultations in primary health care centers. They are clinical entities with varying manifestations, etiologies, 
and severities, ranging from mild to life-threatening infections. They involve microbial invasion of the skin layers 
and soft tissues, followed by a process that leads to clinical effects as a result of the interaction between micro-
organisms and host defenses. Furthermore, the pathophysiology of SSTIs is the result of a complex interplay of 
physiological, immunological, and environmental effects, including microorganism, inflammation, oxidative 
stress, and impaired healing. In immunocompetent hosts, SSTIs can be caused by various microorganisms, 
mainly bacteria and  fungi1–3.
The most common bacteria implicated in SSTIs are Streptococcus pyogenes, Pseudomonas aeruginosa, and 
Staphylococcus aureus, including methicillin-resistant S. aureus strains. Superficial fungal infections are mainly 
caused by dermatophytes and yeasts. Dermatophytes are a group of fungi capable of invading keratinized struc-
tures (skin, hair, and nails), mediated by both keratinases and proteases. The main dermatophytes that cause 
human dermatomycosis belong to the genera Trichophyton, Microsporum, and Epidermophyton, while Candida 
spp. and Malassezia spp. are the most common yeasts. These yeasts are recognized members of the human 
skin microbiota, but under certain conditions they can change their status and act as  pathogens2. In addition, 
Malassezia spp. (lipophilic yeasts) are the most abundant eukaryotes, accounting for approximately 50–80% of 
the total skin  mycobiome4,5.
Due to the increase in strains resistant to antimicrobial agents, skin infections are increasingly difficult to 
treat. Infections caused by drug-resistant microorganisms are associated with high morbidity and mortality and 
consequently higher healthcare  costs6. Therefore, there is a need to find/develop compounds with antimicrobial 
properties that are also cost effective.
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Nanotechnology is an important modern field of research that deals with the synthesis and manipulation of 
matter at the nanometer scale (1 nm =  10–9 m) and the study of its properties and applications. Nanomedicine has 
emerged as an interdisciplinary science that combines knowledge from physics, chemistry, biology, and medicine 
to treat human diseases. Currently, the development of nanoparticle-based products is growing, many of which 
are already on the  market7,8. Noble metal nanoparticles have demonstrated unique and significantly different 
physical and chemical properties than their macroscopic counterparts. As nanoparticles decrease in size, their 
surface to volume ratio, dispersion, and antimicrobial activity  increase7,9–13. Silver is a noble metal with high 
antimicrobial activity and low toxicity in animal cells and has a long history in traditional  medicine11. Various 
silver compounds have been used clinically to reduce skin infections (e.g. silver sulfadiazine). Currently, there 
is a growing interest in the use of silver nanoparticles (AgNPs) for the treatment of SSTIs due to their improved 
 properties8,11.
On the other hand, nanoparticles are usually synthesized through a variety of physical and chemical processes 
that are costly and pollute the environment. For this reason, plant-mediated synthesis has emerged as a green 
synthesis method that utilizes plants as a source of metabolites, mainly phenolic compounds, for the synthesis 
of nanoparticles as an environmentally friendly  technology10,12.
Plants have been used as medicine by various cultures throughout history. Their myriad uses have been docu-
mented and passed down through generations. They are an important source of phenolic compounds, mainly 
flavonoids, many of which have antimicrobial, anti-inflammatory and antioxidant properties that enhance the 
treatment of SSTIs. Acanthospermum australe (Loefl.) Kuntze, commonly known as "tapekué" in Argentina, is 
a medicinal plant used by indigenous peoples in northeastern Argentina to disinfect wounds and skin ulcers, 
among other  uses3,14,15. In addition, silver is used in traditional Indian medicine (Ayurveda) as a therapeutic 
agent to treat various  infections16. The combination of traditional medicine with nanotechnology therefore opens 
the door to innovative strategies for the treatment of SSTIs and also contributes to the fight against the increase 
in antimicrobial resistance.
The objectives of this study were (a) to synthesize and characterize AgNPs using an aqueous extract of A. 
australe (TAE), (b) to analyze the total phenolic and flavonoid content of the extract, (c) to evaluate the antioxi-
dant activity, and (d) to determine and compare the cytotoxicity and antimicrobial activity of the AgNP solution 
and its synthesis components.
Materials and methods
Plant material. All methods were carried out in accordance with the recommendations established in a 
previous work based on the guidelines on good agricultural and collection practices for medicinal plants of the 
World Health Organization and European Medicines  Agency17. The plant material was collected in accordance 
with relevant institutional, national and international guidelines and laws. The leaves of A. australe were har-
vested by hand and dried at room temperature protected from sunlight.
Plant material was collected in Riachuelo, Corrientes, Argentina (27°33′42.0"S 58°43′35.9"W) and taxonomi-
cally identified by Dr. Massimiliano Dematteis of the Instituto de Botánica del Nordeste, Universidad Nacional 
del Nordeste, Argentina. A voucher specimen has been deposited in the herbarium of the Instituto de Medicina 
Regional, Universidad Nacional del Nordeste, Argentina, with the number IMR-H-2017–18.
Preparation of the aqueous extract of A. australe (TAE). Exactly 50  g of the comminuted plant 
material was boiled with 1000 mL of sterile deionized water for 5 min and allowed to stand for 1 h at room 
temperature. It was then filtered using Whatman filter paper No. 1 followed by a Millipore filter (0.22 µm). The 
obtained aqueous extract was frozen at -70 °C, lyophilized and stored at 4 °C in the dark under sterile conditions 
for later use. The percentage yield of extraction (Y) was determined using the following equation:
Total phenolic content. The total phenolic content of TAE was analyzed spectrophotometrically using the 
Folin-Ciocalteu  method18, with some modifications (Supplementary file). The results are expressed as the mean 
gallic acid equivalent mass in mg per g of lyophilized extract (mg GAE/g LE) ± standard deviation (SD).
Total flavonoid content. It was determined for TAE according to Dewanto et al.19, with modifications 
(Supplementary file). Total flavonoid content was expressed as the mean quercetin equivalent mass in mg per g 
of lyophilized extract (mg QE/g LE) ± SD.
Green synthesis of silver nanoparticles. In order to obtain small and stable nanoparticles, the green 
synthesis was carried out according to the results obtained by other  authors12,20,21, with some modifications 
(Supplementary file).
Characterization of silver nanoparticles. The synthesized AgNPs were characterized using the follow-
ing techniques: (A) UV–visible spectrophotometer (Multiskan Go, Thermo Fisher, Finland) was used to measure 
absorbance and record optical density at wavelengths from 300 to 700 nm. (B) The shape and size of AgNPs were 
determined by transmission electron microscopy (TEM; JEOL, Tokyo, Japan; JEM-2100) at an accelerating volt-
age of 200 kV. Samples were prepared by drop coating 10 µL of AgNP solution onto carbon coated copper grids 
followed by air drying, forming a thin layer on the surface. (C) Energy dispersive X-ray spectroscopy (EDX) was 
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performed to determine the elemental composition of the sample. (D) The hydrodynamic size, polydispersity 
index (PDI) and zeta potential of the AgNP colloid were investigated by dynamic light scattering (DLS) using a 
Malvern Zetasizer Nanoseries compact scattering spectrometer (Malvern, UK) at 25 °C. (E) Fourier transform 
infrared spectroscopy (FTIR) with a resolution of 0.2 nm at 40–4000  cm-1 (Nicolet 670, Madison, WI) was used 
to identify the possible biomolecules responsible for the reduction of silver ions and capping of the synthesized 
AgNPs. (F) The colloidal stability of AgNPs over time was evaluated by visual observation and UV–visible spec-
troscopy.
Ferric reducing antioxidant power (FRAP) assay. The antioxidant activity of TAE,  AgNO3 and AgNPs 
was determined using the FRAP assay according to Quiroz-Reyes et al.22 (Supplementary file). The results are 
expressed as the mean Trolox equivalent mass in μmol per g of lyophilized extract (μmol TE/g LE) ± SD.
DPPH radical scavenging capacity. The antiradical capacity was determined using the DPPH (2,2-diphe-
nyl-1-picrylhydrazyl) assay according to the methodology proposed by  Molyneux23, with some modifications 
(Supplementary file). The effective concentration 50%  (EC50), defined as the amount of antioxidant required to 
reduce the initial concentration of DPPH radical by 50%, was calculated. In addition, the percentage of DPPH 
reduction was calculated using the following equation:
Cytotoxicity assay. The cytotoxicity of TAE,  AgNO3, and AgNPs was determined against peripheral blood 
mononuclear cells (PBMCs) as previously  described24, with modifications (Supplementary file). Untreated cells 
were considered as negative control and paclitaxel 2.5 µg/mL (Sigma Aldrich, USA) as positive control. The 
different samples were compared with the negative control and the percent cell viability was calculated. Sam-
ples with viability percentages below 70% were considered cytotoxic according to the recommendations of ISO 
10,993–525.
Microorganisms. A total of 298 microorganisms were examined: 33 Microsporum canis, 19 M. gypseum, 4 
Epidermophyton floccosum, 31 Trichophyton rubrum, 22 T. mentagrophytes, 6 T. tonsurans, 40 Malassezia furfur, 
25 M. sympodialis, 9 M. globosa, 1 M. restricta, 24 C. albicans, 21 C. krusei, 16 C. tropicalis, 11 C. parapsilosis, 6 C. 
glabrata, 8 P. aeruginosa, 8 S. pyogenes, and 14 S. aureus (including 2 methicillin-resistant strains).
All microorganisms were obtained from the culture collection of the Instituto de Medicina Regional, Uni-
versidad Nacional del Nordeste, Argentina. The reference strains M. furfur CBS 7019, M. sympodialis CBS 7222, 
M. globosa CBS 7986, C. albicans ATCC 90,028, C. tropicalis ATCC 750, C. krusei ATCC 6258, C. parapsilosis 
ATCC 22,019, C. glabrata ATCC 2001 and S. aureus ATCC 25,923 were included.
In vitro inhibitory activity. Minimum inhibitory concentration (MIC). To evaluate the inhibitory activity 
of TAE,  AgNO3 and AgNPs, MICs were determined using the broth microdilution method in accordance with 
the CLSI M27 document for  yeasts26,27, CLSI M38 for filamentous  fungi28and CLSI M07 for  bacteria29. Dimethyl 
sulfoxide was used as the solvent (final concentration ≤ 1%).
MIC was determined by visual reading of growth inhibition at three endpoints using the following numerical 
scale: MIC-0 as the lowest concentration capable of inhibiting 100% of microbial growth; MIC-1 as the lowest 
concentration capable of inhibiting ≥ 80% of microbial growth compared to the growth control; and MIC-2 as 
the lowest concentration capable of inhibiting ≥ 50% of microbial growth compared to the growth control. The 
criteria for antimicrobial activity defined in a previous work were  followed17. These criteria specify that plant 
extracts are considered active when MIC-2 ≤ 1024 μg/mL and inactive at higher values, while pure compounds 
are considered active when MIC-2 ≤ 256 μg/mL and inactive at higher values. In this work, AgNP and  AgNO3 
solutions were considered as pure compounds and TAE as plant extract. The inhibitory controls used were: 
itraconazole (ITZ) (Sigma-Aldrich) for fungi, penicillin (PEN) (Sigma-Aldrich) for S. pyogenes, and gentamicin 
(GEN) (Sigma-Aldrich) for S. aureus and P. aeruginosa. For the control drugs, the endpoint values reported in 
the CLSI documents were used.
Minimum fungicidal concentration (MFC) and minimum bactericidal concentration (MBC). The MFC and 
MBC of TAE,  AgNO3 and AgNPs were determined according to the procedures established by other  authors30–33, 
with modifications (Supplementary file). The MBC and MFC were defined as the lowest TAE,  AgNO3 or AgNP 
concentrations at which no colonies were observed.
MFC:MIC and MBC:MIC ratios were calculated for each isolate using the MIC-0 value. By extrapolating 
the conventional definition used for bacterial assays, in this work a compound was considered bactericidal or 
fungicidal if the ratio was ≤ 4, and bacteriostatic or fungistatic if the ratio was >  433,34.
All assays were performed in duplicates. Range and mode values were determined. All MIC, MFC, and MBC 
data were expressed as μg LE/mL for TAE and μg silver/mL for  AgNO3 and AgNPs.
Results
Yield and phytochemical analysis. The process used to obtain the TAE showed a yield of 12%. On 
the other hand, the total phenolic and flavonoid contents of the extract were 155.9 ± 3.9  mg GAE/g LE and 
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Characterization of silver nanoparticles. During green synthesis, the color of the solution changed 
from pale yellow to dark brown within a few min, indicating the formation of AgNP. The main features of the 
synthesized nanoparticles are shown in Fig. 1. The UV–visible spectrum showed a maximum absorption band 
at 410  nm, which corresponds to the local surface plasmon resonance absorption typical of  nanoparticles35. 
The TEM images showed non-agglomerated spherical nanoparticles. The sizes of at least 100 particles were 
measured using ImageJ software. The data were transferred to Origin software for statistical analysis, which 
revealed a diameter of 14 ± 2 nm. DLS analysis revealed strongly anionic nanoparticles with a PDI of 0.269, a 
hydrodynamic diameter of 36 ± 13 nm, and a zeta potential of -37 ± 6 mV. The FTIR spectrum of AgNPs showed 
peaks at about 1636, 2100 and 3300  cm-1. Finally, EDX analysis revealed a strong signal of elemental silver with 
an optical absorption band peak in the range of 3 to 4 keV, which is typical for the absorption of metallic silver 
 nanocrystallites35. In addition, other elemental signals were recorded in smaller amounts.
Antioxidant activity. The results of FRAP and DPPH assays of TAE,  AgNO3 and AgNPs are shown in 
Table 1.
Cytotoxicity assay. The cytotoxicity of TAE,  AgNO3 and AgNPs was evaluated on PBMCs after 24 and 72 h 
incubation, and the results are shown in Fig. 2.
In vitro inhibitory activity. Range and mode values for MIC-2, MIC-1, MIC-0, MFC, MBC, MBC:MIC 
and MFC:MIC obtained with TAE,  AgNO3 and AgNPs against the tested microorganisms are shown in Table 2.
The values obtained with the control drugs were similar to those obtained by other  authors27,36–39, which 
allowed us to confirm that we were working under standardized conditions.
Discussion
In recent years, the World Health Organization (WHO) has emphasized the importance of research and devel-
opment of new antimicrobial drugs as morbidity and healthcare costs have increased due to the rise of resistant 
 strains40. In response, nanoparticles and medicinal plants have emerged as promising alternatives for the treat-
ment of skin  infections3,8,10,11,16,17,41. In addition, the development of more efficient green synthesis methods has 
become an important focus of researchers. Biological synthesis of silver nanoparticles using plants has proven 
to be cost-efficient and environmentally friendly and is a valuable alternative for large-scale  production10,13,41. 
Ayurveda, the traditional Indian medicine, was perhaps the first to use metallic herbal preparations. These 
preparations, often called bhasmas, are used to treat many diseases. Silver bhasma is a medicine known since 
the seventh century BC, obtained after exposure of metallic silver through a series of physico-chemical processes 
in the presence of medicinal herbs. Today, bhasmas are claimed to be biologically produced  nanoparticles42.
Aqueous extract of A. australe (TAE). The selection of plant material for this study was based on the 
ancestral knowledge of indigenous people in northeastern Argentina about medicinal plants for the treatment 
of skin  infections14,43. TAE was used as both reducing and capping agent for AgNP synthesis. The obtained yield 
of 12% from TAE was lower than the values of 17.1%, 22.8% and 28.5% obtained by other  authors44–46. Several 
factors influence this performance, including the plant material used and the extraction methodology, but also 
the place and time of collection, the chemical nature of the metabolites present in the plant, and their affinity for 
the  solvent47. It has been shown that growth conditions lead to changes in plant composition, which translates 
into changes in extraction  yield17.
On the other hand, chemical analysis of TAE revealed the presence of phenolic compounds, mainly flavo-
noids. Similar to other reports, the presence of these compounds was also detected in tapekué extracts, which 
are associated with antimicrobial properties and are responsible for the reducing property of the  extract48–50. 
Likewise, it is known that the flavonoids contained in the aqueous plant extracts are mainly responsible for the 
reduction of silver ions and the formation of stable  nanoparticles13,21,41.
Silver nanoparticles (AgNPs). In this work, the ionized chemical groups present in the extract allowed 
the rapid formation of AgNPs when TAE was mixed with  AgNO3 solution at pH 9.5. The color change indicated 
the presence of AgNPs in the solution.
TEM images were used to determine the size of the metallic core and DLS to determine the hydrodynamic 
size, i.e., the size of the nanoparticle in solution including the metallic core, the coating phytochemicals, and the 
solvent layer. TEM images confirmed the presence of AgNPs with sizes and shapes similar to those obtained by 
other authors with other  plants41. DLS analysis revealed a monomodal population. Moreover, absolute values of 
zeta potential higher than 30 mV indicate stable nanoparticles, which could be related to the electrostatic repul-
sion of the anions present in the colloidal  suspension51. These results explain the good stability of the synthesized 
AgNPs, which remained stable as colloids for more than 6 months.
EDX analysis verified the purity of the AgNPs and the presence of traces of other elements that could have 
originated from the biomolecules of TAE that were bound to the surface of the nanoparticles. FTIR analysis 
allowed us to identify the functional groups responsible for the reduction of silver ions. It revealed peaks at 1636, 
2100 and 3300  cm-1 corresponding to the C = O functional groups of the amide (1640  cm-1), the C≡C stretch 
(2100  cm-1) and the N–H/O–H vibrational stretch of the amine (3370  cm-1), which are similar to the functional 
groups of AgNPs synthesized with  quercetin21. In addition, other authors have shown that quercetin is present 
in tapekué  extracts48,52. The results obtained in this work suggest that quercetin could be the main metabolite 
responsible for the reduction of silver ions to AgNPs, according to Jain et al.21. Moreover, the obtained value of 
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negative zeta potential could be due to the hydroxyl groups of quercetin present on the surface of the nanopar-
ticles, generating a negative charge on these particles.
Figure 1.  Characteristics of the synthesized AgNPs from TAE. (A) UV–visible spectrum. (B) Histogram of 
particle size distribution. (C) TEM image. (D) FTIR spectra. (E) EDX spectra.
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Quercetin (3,3′,4′,5,7-pentahydroxylflavone) is a typical phenolic compound. It is a flavonoid widely distrib-
uted in the plant kingdom and one of the most important compounds in some plants, exhibiting anti-inflam-
matory, anti-allergic and protective properties against various diseases associated with oxidative stress. In recent 
years, this flavonoid has attracted much attention, especially as an antioxidant  agent53.
Antioxidant activity. In this work, TAE showed significant antioxidant activity. In contrast,  AgNO3 solu-
tion showed no activity, while AgNPs showed lower antioxidant activity (55%) than the TAE in both assays 
(DPPH and FRAP). This resulted in the inability to determine the  EC50 for AgNP and  AgNO3 solutions. The 
activity shown by AgNPs could be due to the phenolic compounds of TAE present on the surface of the nano-
particles, which act as antioxidants and capping agents.
The antioxidant property of a plant is given mainly by the composition and concentration of phenolic com-
pounds and to a lesser extent by other components. Phenolic compounds are involved in the stabilization of free 
radicals and metals by acting as electron donors. The antioxidant activity of many polyphenols results essentially 
from the ease with which the hydroxyl group is donated to a free radical and the ability of the aromatic structure 
to carry an unpaired  electron54. The results show that TAE is rich in phenolic compounds, which justifies its 
higher antioxidant activity. Therefore, TAE polyphenols played an important role both as silver ion reducing 
agents and AgNP capping agents.
Cytotoxic activity. The cytotoxicity of TAE,  AgNO3 and AgNP solutions was studied on PBMCs. PBMCs 
are cells of the immune system consisting of lymphocytes (T cells, B cells, NK cells) and monocytes. Cytotoxicity 
on PBMCs represents the potential for immune responses and immunotoxicity and allows prediction of immune 
effects during preclinical safety evaluation. It also helps to understand the interactions between nanomaterials 
and cells of the immune  system55.
Cytotoxicity assays of the components used for the synthesis of the nanoparticles showed that  AgNO3 was 
cytotoxic, while TAE was not cytotoxic to PBMCs at the concentrations evaluated. Moreover, the plant extract 
induced low cell proliferation compared to untreated cells. It has been reported that metabolites present in plants, 
mainly phenolic compounds, affect the nonspecific immune response by mainly increasing phagocytosis and 
proliferation of macrophages and  neutrophils56. The non-toxicity property shown by TAE is of utmost impor-
tance in the context of AgNP production for medicinal applications, especially as a potential topical treatment 
for skin infections.
On the other hand, AgNP solution showed variations in cell viability as a function of dose and time. Cell 
viability reached values below 70% only at AgNP concentrations ≥ 16 µg/mL after 24 h of incubation, but was 
above 70% after 72 h of incubation, indicating the non-cytotoxicity of the synthesized nanoparticles at the tested 
 concentrations25.
Since  AgNO3 was cytotoxic, while AgNPs and TAE were found to be non-cytotoxic and even TAE showed a 
slight proliferative effect, we can conclude that the reduction in cell viability shown by the synthesized AgNPs is 
related to the silver content, but TAE metabolites present on the surface of the nanoparticles reduce the cytotoxic 
effect and modulate the immune response. Therefore, the use of silver in humans may have toxic effects, but these 
effects can be attenuated when silver is incorporated as coated nanoparticles. In other words, a certain amount 
of silver in the form of silver ions is more toxic than the same amount in the form of nanoparticles coated with 
phytocompounds.
Our results are in agreement with those of Orta-García et al.57 who showed that uncoated AgNPs induce 
significant cytotoxic effects on PBMCs at relatively low concentrations (< 5 μg/mL) and short exposure times (3 
to 12 h), suggesting that the coating reduces the area of the active surface of AgNPs and thus the sites of interac-
tion with cellular components.
Antimicrobial activity. The antimicrobial activity of AgNPs,  AgNO3 and TAE, was tested against 298 fungi 
and bacteria causing SSTIs. Three endpoint values (MIC-0, MIC-1, and MIC-2) were used along with the deter-
mination of CFM, as there is still no consensus on which is the best predictor of the in vivo behavior of these 
compounds.
Although tapekué is used in traditional medicine to treat skin infections, TAE was inactive against the 
microorganisms tested in this work. However, considering the possibility of poor water solubility of the active 
compound, we cannot claim that the plant lacks this well-known traditional property. This position is in agree-
ment with the results of Portillo et al.45, who showed that tapekué extracts obtained with organic solvents had 
higher antimicrobial activity than the aqueous extract.




TAE 306.5 ± 1.6 77.7 ± 1.8 596 ± 10
AgNO3 ND 3.6 ± 1.2 0 ± 0
AgNPs ND 35.2 ± 0.4 279 ± 1
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Figure 2.  Percent cell viability after 24 and 72 h of incubation. Results are expressed as (A) µg LE/mL for TAE; 
(B) µg silver/mL for AgNPs; and (C) μg silver/mL  AgNO3. Negative control: untreated cells. Positive control: 
paclitaxel (2.5 μg/mL). For each treatment and control group, the number of determinations was ≥ 12. The 
symbol *indicates a statistically significant difference from the negative control at P between 0.0137 and 0.0436; 
the symbol (#) indicates a statistically significant difference from the negative control at P between 0.0051 and 
0.0067; the symbol (+) indicates a statistically significant difference from the negative control at P < 0.0001.
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Species (N) Compound
MIC-2 MIC-1 MIC-0 MFC | MBC
MFC:MIC | 
MBC:MIC
Range Mode Range Mode Range Mode Range Mode Range Mode
M. canis (33)
TAE  > 1024 ND  > 1024 ND  > 1024 ND ND ND ND ND
AgNO3 2–32 8 4–64 16 16–512 128 32–1024 512 2–8 4
AgNPs 1–8 1 1–16 2 2–32 4 4–32 16 1–4 2
ITZ ND ND  < 0.015–0.125 ND ND ND ND ND ND ND
M. gypseum (19)
TAE  > 1024 ND  > 1024 ND  > 1024 ND ND ND ND ND
AgNO3 32–128 64 32–128 64 128–1024 512 512–1024 1024 2–8 4
AgNPs 4–8 4 4–16 8 8–32 16 16–32 16 1–2 1
ITZ ND ND  < 0.015–0.25 ND ND ND ND ND ND ND
E. floccosum (4)
TAE  > 1024 ND  > 1024 ND  > 1024 ND ND ND ND ND
AgNO3 2–4 4 2–4 4 4–8 8 8–16 16 1–2 2
AgNPs 1–4 1 1–4 2 2–4 4 4–8 8 1–2 2
ITZ ND ND  < 0.015–0.03 ND ND ND ND ND ND ND
T. rubrum (31)
TAE  > 1024 ND  > 1024 ND  > 1024 ND ND ND ND ND
AgNO3 4–32 16 4–64 16 16–128 32 32–512 64 2–4 4
AgNPs 0.25–4 2 0.5–4 2 0.5–4 4 1–16 16 1–4 4
ITZ ND ND  < 0.015–0.5 ND ND ND ND ND ND ND
T. mentagrophytes (22)
TAE  > 1024 ND  > 1024 ND  > 1024 ND ND ND ND ND
AgNO3 8–32 16 8–32 32 8–128 32 32–256 64 2–4 4
AgNPs 4–8 8 4–16 8 8–6 16 16–32 16 1–2 2
ITZ ND ND  < 0.015–1 ND ND ND ND ND ND ND
T. tonsurans (6)
TAE  > 1024 ND  > 1024 ND  > 1024 ND ND ND ND ND
AgNO3 4–16 8 4–32 8 8–32 16 16–64 32 2–4 2
AgNPs 0.25–2 2 0.5–4 2 1–4 4 4–8 4 2–4 2
ITZ ND ND  < 0.015–0.125 ND ND ND ND ND ND ND
M. furfur (40)
TAE  > 1024 ND  > 1024 ND  > 1024 ND ND ND ND ND
AgNO3 1–8 4 1–8 4 2–8 8 4–32 16 2–4 2
AgNPs 0.06–4 0.125 0.125–4 0.125 0.125–4 0.25 0.25–8 0.5 1–4 2
ITZ 0.03–0.125 0.03 ND ND ND ND ND ND ND ND
M. furfur CBS 7019 ITZ ND 0.03 ND ND ND ND ND ND ND ND
M. sympodialis (25)
TAE  > 1024 ND  > 1024 ND  > 1024 ND ND ND ND ND
AgNO3 0.25–4 2 0.5–4 2 1–4 4 2–16 8 2–4 2
AgNPs 0.015–2 0.125 0.03–2 0.125 0.03–4 0.25 0.06–4 0.25 1–4 2
ITZ 0.015–0.06 0.03 ND ND ND ND ND ND ND ND
M. sympodialis CBS 
7222 ITZ ND 0.03 ND ND ND ND ND ND ND ND
M. globosa (9)
TAE  > 1024 ND  > 1024 ND  > 1024 ND ND ND ND ND
AgNO3 0.25–1 0.5 0.25–2 0.5 0.5–4 2 1–16 8 2–4 2
AgNPs 0.06–0.25 0.06 0.06–0.25 0.125 0.125–0.5 0.125 0.125–1 0.125 1–4 2
ITZ 0.015–0.06 0.03 ND ND ND ND ND ND ND ND
M. globosa CBS 7986 ITZ ND 0.015 ND ND ND ND ND ND ND ND
M. restricta (1)
TAE  > 1024 ND  > 1024 ND  > 1024 ND ND ND ND ND
AgNO3 ND 0.5 ND 1 ND 2 ND 4 ND 2
AgNPs ND 0.25 ND 0.5 ND 1 ND 1 ND 1
ITZ ND 0.03 ND ND ND ND ND ND ND ND
C. albicans (24)
TAE  > 1024 ND  > 1024 ND  > 1024 ND ND ND ND ND
AgNO3 1–16 8 1–32 16 2–32 32 4–128 64 2–4 4
AgNPs 0.25–8 0.5 0.25–16 2 0.5–16 4 2–32 8 2–4 4
ITZ  < 0.015–0.125 ND ND ND ND ND ND ND ND ND
C. albicans ATCC 90028 ITZ ND 0.125 ND ND ND ND ND ND ND ND
C. krusei (21)
TAE  > 1024 ND  > 1024 ND  > 1024 ND ND ND ND ND
AgNO3 1–16 8 1–32 16 2–32 32 4–128 64 2–4 4
AgNPs 0.25–4 0.5 0.25–8 1 0.5–16 4 2–32 8 2–4 4
ITZ  < 0.015–0.5 ND ND ND ND ND ND ND ND ND
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AgNO3 showed antimicrobial activity but with higher MIC and CFM values than those of the synthesized 
nanoparticles, and its toxicity precludes it as an antimicrobial agent. Therefore, AgNP solution was a better 
antimicrobial agent than the components used for its synthesis (Fig. 3).
Variations in MIC and CFM values were observed between isolates of the same species and between species 
of the same genus. These variations highlight the importance of testing multiple isolates in the evaluation of 
antimicrobial activity.
According to the MFC values, the tested S. pyogenes strains and Malassezia species were most inhibited by 
AgNPs. M. globosa, the main causative agent of pityriasis versicolor and seborrheic  dermatitis5, was the most sus-
ceptible microorganism to the synthesized nanoparticles. Moreover, methicillin-resistant S. aureus strains were 
inhibited by AgNPs. This indicates the potential use of AgNPs as antimicrobial agents against fungi and bacteria.
The values of MFC:MIC ratio obtained for AgNPs against the tested fungi were consistent with fungicidal 
activity. However, a different behavior was obtained against bacteria. According to the mode values obtained for 
MBC:MIC ratios, AgNPs showed bactericidal activity, but some strains of S. aureus and P. aeruginosa showed 
values ≥ 4 associated with bacteriostatic activity.
MIC-0 and MFC values greater than 1024 μg/mL were obtained for  AgNO3 against bacteria; therefore, the 
MFC:MIC ratio could not be determined. However, the MIC-2 values were determined. In addition, sustained 
growth was observed at  AgNO3 concentrations above the MIC-2 (trailing effect). This effect occurs with drugs 
that have bacteriostatic activity and is not normally observed with bactericidal drugs. Although  AgNO3 may 
have a bacteriostatic effect, we did not consider  AgNO3 itself as an antimicrobial agent because of its toxicity.
The use of less stringent endpoint readings, such as MIC-2 and MIC-1, is associated with drugs with 
fungistatic/bacteriostatic activity, whereas MIC-0 is generally associated with drugs with biocidal  activity28,29. 
Species (N) Compound
MIC-2 MIC-1 MIC-0 MFC | MBC
MFC:MIC | 
MBC:MIC
Range Mode Range Mode Range Mode Range Mode Range Mode
C. tropicalis (16)
TAE  > 1024 ND  > 1024 ND  > 1024 ND ND ND ND ND
AgNO3 1–8 8 1–16 8 2–32 16 4–64 32 2–4 4
AgNPs 0.25–4 0.5 0.5–8 1 1–16 4 2–32 8 2–4 2
ITZ  < 0.015–0.125 ND ND ND ND ND ND ND ND ND
C. tropicalis ATCC 750 ITZ ND 0.125 ND ND ND ND ND ND ND ND
C. parapsilosis (11)
TAE  > 1024 ND  > 1024 ND  > 1024 ND ND ND ND ND
AgNO3 1–128 16 2–128 32 2–128 32 4–256 64 2–4 2
AgNPs 0.5–4 2 1–8 4 1–16 8 2–32 16 2–4 2
ITZ  < 0.015–0.125 ND ND ND ND ND ND ND ND ND
C. glabrata (6)
TAE  > 1024 ND  > 1024 ND  > 1024 ND ND ND ND ND
AgNO3 1–16 4 1–32 16 2–32 16 4–128 64 2–4 4
AgNPs 0.25–4 1 0.5–8 2 1–8 4 2–32 16 2–4 4
ITZ 0.015–0.5 0.03 ND ND ND ND ND ND ND ND
C. glabrata ATCC 2001 ITZ ND 0.5 ND ND ND ND ND ND ND ND
S. aureus (14)
TAE  > 1024 ND  > 1024 ND  > 1024 ND ND ND ND ND
AgNO3 8–64 32  > 1024 ND  > 1024 ND ND ND ND ND
AgNPs 0.5–4 1 1–8 4 2–16 8 8–64 32 4–8 4
GEN ND ND ND ND 0.25–4 0.5 ND ND ND ND
S. aureus ATCC 25923 GEN ND ND ND ND ND 0.25 ND ND ND ND
P. aeruginosa (8)
TAE  > 1024 ND  > 1024 ND  > 1024 ND ND ND ND ND
AgNO3 4–64 16  > 1024 ND  > 1024 ND ND ND ND ND
AgNPs 0.5–2 1 1–4 2 1–4 2 4–32 8 4–8 4
GEN ND ND ND ND 0.125–2 0.5 ND ND ND ND
S. pyogenes (8)
TAE  > 1024 ND  > 1024 ND  > 1024 ND ND ND ND ND
AgNO3 8–32 16  > 1024 ND  > 1024 ND ND ND ND ND
AgNPs 0.015–0.5 0.125 0.015–0.5 0.125 0.015–1 0.25 0.06–2 0.5 1–4 2
PEN ND ND ND ND  < 0.015–0.03 ND ND ND ND ND
Table 2.  Range and mode values of MIC-0, MIC-1, MIC-2, MFC, MBC and MIC:MFC or MBC:MIC of the 
aqueous extract of A. australe (TAE), silver nitrate  (AgNO3), silver nanoparticles (AgNPs), itraconazole (ITZ), 
penicillin (PEN) and gentamicin (GEN) against the microorganisms tested. All MIC, MFC and MBC data were 
expressed as μg lyophilized extract/mL for TAE and μg silver/mL for  AgNO3 and AgNPs. ND: Not determined. 
MIC-2: the lowest concentration capable of inhibiting ≥ 50% of microbial growth compared to the growth 
control. MIC-1: the lowest concentration capable of inhibiting ≥ 80% of microbial growth compared to the 
growth control. MIC-0: the lowest concentration capable of inhibiting 100% of microbial growth. Compounds 
with MIC values > 1024 μg/mL were considered inactive. A compound was considered bactericidal or 
fungicidal if the ratio (MFC:MIC or MBC:MIC) was ≤ 4, and bacteriostatic or fungistatic if the ratio was > 4.
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Consequently, MIC-0 could be considered as the best endpoint reading for AgNPs against the tested fungi and 
bacteria.
To confirm fungicidal or bactericidal activity, further studies, such as time-kill assays, are needed to cor-
relate these results. In addition, it is important to note that the choice of endpoint reading for a clinical drug is 
based on the distribution of their MIC, pharmacokinetic and pharmacodynamic parameters, animal models, 
and therapeutic  outcomes58.
The reasons for the excellent antimicrobial activity of AgNPs are not yet clear. However, it is known that the 
mode of action of AgNPs is the result of several simultaneous processes by which AgNPs can circumvent most 
microbiological resistance mechanisms that occur with classical antimicrobial agents. Therefore, new strategies 
against multidrug-resistant microorganisms are increasingly based on the search for synergistic effects between 
antimicrobial agents of clinical use and metallic  nanoparticles16,59.
Conclusion
In summary, green synthesis using TAE proved to be a simple, environmentally friendly and economical method 
for the preparation of AgNPs with improved properties compared to their synthesis components.
AgNPs were not cytotoxic at the concentrations required to inhibit microbial growth, whereas  AgNO3 was 
cytotoxic. AgNPs were fungicidal and bactericidal, while  AgNO3 was fungicidal but bacteriostatic. TAE was 
inactive against the main microorganisms causing SSTIs and not cytotoxic to PBMCs.
The antimicrobial activity of AgNPs is due to the silver and not to the phytocompounds present on the sur-
face of the nanoparticles. TAE plays a more important role in the formation of stable AgNPs and possibly as a 
modulator of cytotoxic and immune response.
The combination of traditional medicine with nanotechnology gives us a great opportunity to develop new 
antimicrobial agents. This work enabled us to rediscover a technology formerly known as bhasmas for the treat-
ment and prevention of SSTIs.
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